CENTOGENE NV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CENTOGENE NV and buy or sell other stocks, ETFs, and their options commission-free!About CNTGF
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate.
CEODavid Jiménez
CEODavid Jiménez
Employees493
Employees493
HeadquartersRostock, Mecklenburg-Vorpommern
HeadquartersRostock, Mecklenburg-Vorpommern
Founded2018
Founded2018
Employees493
Employees493
CNTGF Key Statistics
Market cap3.01M
Market cap3.01M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume230.00
Average volume230.00
High today$0.1022
High today$0.1022
Low today$0.1002
Low today$0.1002
Open price$0.1002
Open price$0.1002
Volume200.00
Volume200.00
52 Week high$0.705
52 Week high$0.705
52 Week low$0.0003
52 Week low$0.0003
Stock Snapshot
With a market cap of 3.01M, CENTOGENE NV(CNTGF) trades at $0.10.
As of 2025-11-25, CENTOGENE NV(CNTGF) stock has fluctuated between $0.10 and $0.10. The current price stands at $0.10, placing the stock +2.0% above today's low and 0.0% off the high.
The CENTOGENE NV(CNTGF)'s current trading volume is 200, compared to an average daily volume of 230.
During the past year, CENTOGENE NV(CNTGF) stock moved between $0.00 at its lowest and $0.71 at its peak.
During the past year, CENTOGENE NV(CNTGF) stock moved between $0.00 at its lowest and $0.71 at its peak.
People also own
Based on the portfolios of people who own CNTGF. This list is generated using Robinhood data, and it’s not a recommendation.